Browsing Centre for Molecular Oncology by Author "Gao, D"
Now showing items 1-3 of 3
-
Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
Wang, P; Li, X; Wang, J; Gao, D; Li, Y; Li, H; Chu, Y; Zhang, Z; Liu, H; Jiang, G (2018-01-10)The originally published version of this Article contained errors in Figure 4. In panel b, the square and diamond labels associated with the uppermost survival curve were incorrectly displayed as 'n' and 'u', respectively. ... -
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
Wang, P; Li, X; Wang, J; Gao, D; Li, Y; Li, H; Chu, Y; Zhang, Z; Liu, H; Jiang, G (2017-11-09)Interleukin-12 (IL-12) has emerged as one of the most potent agents for anti-tumor immunotherapy. However, potentially lethal toxicity associated with systemic administration of IL-12 precludes its clinical application. ... -
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer
Lu, S; Zhang, Z; Du, P; Chard, LS; Yan, W; El Khouri, M; Wang, Z; Zhang, Z; Chu, Y; Gao, D (2020-01-15)